Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 21, 2026 in Microvast Holdings, Inc. Lawsuit - MVST

Alert: Claims Focus on Alleged EMEA Customer Ramp-Up Delays and ESS Inventory Impairment. The lawsuit alleges Microvast overstated its ability to sustain high margins while customer rollout delays and specialized inventory issues were allegedly undermining results.

NEW YORK, Sept. 16, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Microvast Holdings, Inc. (NASDAQ: MVST) that a class action has been filed on behalf of shareholders who purchased securities between April 1, 2025 and March 16, 2026. Find out if you might qualify for recovery or call (212) 363-7500.

MVST shares fell $0.79 per share, or 34.2%, to close at $1.52 on March 17, 2026. Microvast reported Q4 2025 revenue of $96.5 million versus a $136.4 million consensus estimate, a gross margin of 1.0%, and a $32.5 million inventory impairment charge. The lead plaintiff deadline is September 21, 2026.

Alleged Operational Shortfall in EMEA Customer Rollouts

The complaint contends that Microvast attributed its Q4 2025 revenue miss partly to delays in customer platform ramp-up in Europe, the Middle East, and Africa. Earlier in the Class Period, the Company allegedly continued to point investors toward growth tied to customer demand and higher-margin opportunities.

As pleaded, these rollout delays allegedly made Microvast's margin targets less achievable than investors were led to believe. The case claims investors were not adequately warned that customer timing issues could materially affect revenue and gross margin performance.

Alleged ESS Inventory and Margin Impact by the Numbers

• Microvast reported Q4 2025 gross margin of 1.0%, down from 36.6% in Q4 2024.
• The Company recorded a $32.5 million inventory impairment charge tied to specialized ESS components.
• The impairment allegedly related to inventory manufactured for a customer that did not generate associated revenue during 2025.
• The impairment negatively affected gross margin by 30.1 percentage points for the quarter.
• The lawsuit alleges the impairment and customer rollout delays contradicted prior margin expectations.

Why the Operational Allegations Matter to MVST Investors

The action claims the operational issues were material because Microvast had provided investors with revenue guidance of $450 million to $475 million and repeatedly emphasized margin expansion. When the Company later reported the revenue miss and margin collapse, investors allegedly suffered losses as MVST shares declined sharply.

Timely disclosure of material operational developments is fundamental to fair and efficient markets, particularly where margin targets depend on customer ramp timing and usable inventory. Here, the complaint raises questions about whether investors received complete information before the reported $32.5 million impairment and 34.2% stock decline. -- Joseph E. Levi, Esq.

Submit your information now or call (212) 363-7500.

WHY LEVI & KORSINSKY — Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors. Investors who suffered losses have until September 21, 2026 to seek appointment as lead plaintiff.

Frequently Asked Questions About the MVST Lawsuit

Q: What is the MVST class action lawsuit about? A: A securities class action has been filed against Microvast Holdings, Inc. (NASDAQ: MVST) alleging materially false and misleading statements between April 1, 2025 and March 16, 2026. Shares fell approximately 34.2% after the Company reported a Q4 2025 revenue miss, a gross margin decline to 1.0%, and a $32.5 million inventory impairment charge. Investors who purchased shares during the Class Period and suffered losses may be eligible to seek compensation.

Q: What specific misstatements does the MVST lawsuit allege? A: The complaint alleges Microvast made materially false or misleading statements regarding its ability to reach gross margin targets, complete the Huzhou Phase 3.2 expansion by the end of 2025, and manage inventory and customer rollout risks during the Class Period. When the Company reported the Q4 2025 revenue miss, 1.0% gross margin, and $32.5 million inventory impairment, the stock price declined sharply.

Q: What court was the MVST class action filed in? A: The case was filed in the United States District Court for the Southern District of Texas, Houston Division, governed by the Private Securities Litigation Reform Act of 1995.

Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.

Q: What documents do I need to submit my information? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my MVST shares, can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: What does it cost me to participate? A: There is no upfront cost to contact the firm. Securities class actions are generally handled on a pure contingency basis. No upfront fees, no retainer, and no out-of-pocket costs. Any attorneys' fees and expenses awarded to class counsel are subject to court approval.

CONTACT:\
Levi & Korsinsky, LLP\
Joseph E. Levi, Esq.\
Ed Korsinsky, Esq.\
33 Whitehall Street, 27th Floor\
New York, NY 10004\
[email protected]\
Tel: (212) 363-7500\
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE Levi & Korsinsky, LLP